Celgene Corporation Strategy and SWOT Report

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Oral Proteins and Peptides Market (2nd edition), 2015 - 2025

Oral Proteins and Peptides Market (2nd edition), 2015 - 2025

  • $ 1 899
  • Industry report
  • by Roots Analysis Private Ltd.
  • January 2015
  • 175 pages

The “Oral Proteins and Peptides Market (2nd edition), 2015-2025” report provides a comprehensive analysis of the current state of the market and the likely future evolution over the next ten years. Endogenous peptides are a smart way to utilise body's own resources to design drugs that are more specific ...

Industries: Biopharmaceutical | Countries: United States

XTL BIopharmaceuticals Limited

XTL BIopharmaceuticals Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 56 pages

A textual analysis of the financial results for XTL BIopharmaceuticals Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical | Countries: Israel, United States

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Medical Equipment - Deals and Alliances Profile

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • January 2015
  • 14 pages

Summary Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a healthcare service provider. The company provides drug and clinical development service to biopharmaceutical companies. Its preclinical services include SNBL USA preclinical expertise, SNBL preclinical drug safety research (DSR) expertise, ...

Industries: Biopharmaceutical | Countries: United States

Hycor Biomedical Inc. - Medical Equipment - Deals and Alliances Profile

Hycor Biomedical Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • January 2015
  • 19 pages

Summary Hycor Biomedical Inc. (Hycor) is an in vitro diagnostics products manufacturer and marketer. The company manufactures and markets systems and testing products for in vitro allergy and autoimmune disorders. Its products include ultra-sensitive EIA system, ELISA microplate assay kits, 288 plus ...

Industries: Biopharmaceutical | Countries: United States

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Abnova Corporation SWOT Analysis report provides you a strategic analysis ...

Industries: Biopharmaceutical | Countries: United States, Taiwan, Japan

Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Advanced BioMedical Technologies, Inc. SWOT Analysis report provides ...

Industries: Biopharmaceutical | Countries: United States

Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Aqua Bounty Technologies, Inc. SWOT Analysis report provides you a ...

Industries: Biopharmaceutical | Countries: United States

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. biOasis Technologies Inc. SWOT Analysis report provides you a strategic ...

Industries: Biopharmaceutical | Countries: United States, Canada

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Entest BioMedical Inc. SWOT Analysis report provides you a strategic ...

Industries: Biopharmaceutical | Countries: United States

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Innate Pharma SA SWOT Analysis report provides you a strategic analysis ...

Industries: Biopharmaceutical | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.